CompletedNot Applicable

Maxillary Sinus Augmentation by Xenograft Mixed With Melatonin

Egypt16 participantsStarted 2024-01-09

Plain-language summary

The possibility of enhancing the bone substitute in the maxillary sinus by mixing it with the melatonin to allow proper implant placement in early stage . The aim of the study was to evaluate clinically, radiographically and histologically the effect of melatonin in enhancement of bone healing after augmentation of the maxillary sinus.

Who can participate

Age range25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult male/female patients above the age of 25.
✓. Patients with one or more teeth requiring implant supported dental restoration in atrophic maxilla (unilateral or bilateral).
✓. Alveolar bone height less than 4 mm at the defective site.
✓. Good oral hygiene.

Exclusion criteria

✕. Medically compromised patients with conditions contraindicating surgery (eg. uncontrolled diabetics, bisphosphonate intake, radio or chemotherapy).
✕. Patients with active infection at or related to the site of surgery (eg. acute sinusitis).
✕. Heavy smokers.
✕. Patients not indicated for an implant supported restoration at the time of enrollment (eg. active/untreated periodontal disease).

What they're measuring

Alveolar Bone Height

Timeframe: 8 months

Trial details

NCT IDNCT06736821

Sponsorrehab soliman

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-23

View on ClinicalTrials.gov More Bone Healing trials